Free Trial

Rapport Therapeutics (RAPP) Earnings Date, Estimates & Call Transcripts

$18.85
-0.15 (-0.79%)
(As of 03:08 PM ET)

Earnings Summary

Upcoming
Earnings Date
Nov. 14Estimated
Actual EPS
(Aug. 8)
-$1.70 Missed By -$1.02
Consensus EPS
(Aug. 8)
-$0.68
Skip Charts & View Estimated and Actual Earnings Data

RAPP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RAPP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Rapport Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate:($3.46) EPS
Next Year EPS Consensus Estimate: ($3.04) EPS

RAPP Earnings Date and Information

Rapport Therapeutics last posted its earnings results on August 8th, 2024. The reported ($1.70) earnings per share for the quarter, missing analysts' consensus estimates of ($0.68) by $1.02. Rapport Therapeutics has generated $0.00 earnings per share over the last year. Earnings for Rapport Therapeutics are expected to grow in the coming year, from ($3.46) to ($3.04) per share. Rapport Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off prior year's report dates.

Rapport Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/14/2024
(Estimated)
------- 
8/8/2024-($0.68)($1.70)($1.02)($1.70)--    

Rapport Therapeutics Earnings - Frequently Asked Questions

When is Rapport Therapeutics's earnings date?

Rapport Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates. Learn more on RAPP's earnings history.

Did Rapport Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Rapport Therapeutics (NASDAQ:RAPP) missed the analysts' consensus estimate of ($0.68) by $1.02 with a reported earnings per share (EPS) of ($1.70). Learn more on analysts' earnings estimate vs. RAPP's actual earnings.

How can I listen to Rapport Therapeutics's earnings conference call?

The conference call for Rapport Therapeutics's latest earnings report can be listened to online. Listen to Conference Call

How can I read Rapport Therapeutics's conference call transcript?

The conference call transcript for Rapport Therapeutics's latest earnings report can be read online. Read Transcript

What is Rapport Therapeutics's EPS forecast for next year?

Rapport Therapeutics's earnings are expected to grow from ($3.46) per share to ($3.04) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:RAPP) was last updated on 9/16/2024 by MarketBeat.com Staff

From Our Partners